86
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Poster: found
      Is Open Access

      Lung Adenocarcinoma induced pulmonary embolism progression even on anticoagulant treatment

      Published
      poster
      Bookmark

            Abstract

            A 45 years old, male patient. He had recently diagnosis of adenocarcinoma on right upper lobe of the lung stage IV. He got bilateral pulmonary embolism as complications of lung adenocarcinoma since 25 days and he was on rivaroxaban 15 mg per day as anticoagulant . At that time of presentation in our ED he did not receive chemotherapy but he got appointment to receive it after 5 days. He presented to our ED for haemoptysis since 20 days and shortness of breath with chest tightness since one day. On exam he had vital signs as heart rate was 100 and oxygen saturation was 97% . ECG was unremarkable, chest x ray showed more white patches in the right lung by the comparison with the previous chest X ray . The CT angio-pulmonary decided that showed more progression in the pulmonary embolism PE . The lab result showed; INR was 3.7, D dime was 6.25 ,PT was 46.2 , otherwise non-significant result . He got admission for embolectomy then the decision change to enoxaparin therapeutic dose. The patient was under care of our oncology team

            Content

            Author and article information

            Journal
            ScienceOpen Posters
            ScienceOpen
            22 December 2023
            Affiliations
            [1 ] Hamad Medical Corporation HMC , Qatar ;
            [2 ] HMC , Qatar ;
            Author notes
            Author information
            https://orcid.org/0000-0002-4113-318X
            Article
            10.14293/P2199-8442.1.SOP-.PIFHKI.v1
            d24045ee-9654-4722-9caf-4317398a4fa7

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            : 22 December 2023
            Categories

            The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
            Emergency medicine & Trauma
            Adenocarcinoma , pulmonary embolism , Rivaroxaban and anticoagulant

            Comments

            Comment on this article